Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Oropharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Cardiotoxicity 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Cisplatin 25Cetuximab 12Radiotherapy 11Docetaxel 11Fluorouracil 9Carboplatin 9Surgical Procedures, Operative 8Radiotherapy, Intensity-Modulated 8pembrolizumab 7Magnetic Resonance Spectroscopy 7Radiation 6Surveys and Questionnaires 5Specimen Handling 5Drug Therapy 5toripalimab 4Standard of Care 4Celecoxib 41,2-diaminocyclohexaneplatinum II citrate 4X-Rays 3Platinum 3Paclitaxel 3Nutritional Status 3Interviews as Topic 3Hydroxyurea 3Counseling 3Biopsy 3130-nm albumin-bound paclitaxel 3Taxes 2Resistance Training 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Laryngeal Neoplasms × Fluorophotometry × Clear all
NCT00002964 2013-02-05

Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer

Roswell Park Cancer Institute

Phase 2 Completed
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡